REVENUE CYCLE PERFORMANCE

Don't Just Work Denials. Understand Why They're Happening.

Denial management is both a recovery operation and an upstream prevention engine. Organizations that only work denied claims in the back office without eliminating root causes in scheduling, authorization, and coding remain trapped in permanent rework.

With an average rework cost of $25 to $118 per denied claim plus permanent write-offs on unworked balances, a 10% denial rate on a $30M medical group routinely destroys $1M to $2.5M in annual net cash flow.

RCM Advisory Partners evaluates denial management as an integrated clinical-to-financial control system rather than an isolated billing task. Before recommending workflow redesign, EHR reconfiguration, vendor remediation, or outsourcing, our advisors trace every variance to claim-level data, payer contract terms, and front-to-back staff execution.

What Denial Management Entails: Payer Rules, Coding & EDI Mechanics

Across commercial and government payers, initial denial rates have climbed to 8%–15%+ of submitted charges. Industry studies show that 50% to 65% of denied claims are never reworked or appealed because billing teams lack clinical appeal templates, specialty coding support, or bandwidth.

Effective denial management segments every 835 zero-pay and partial-pay event by Group Code (CO, PR, OA, PI) and CARC/RARC category: Front-End Eligibility/Registration (CARC 22, 27, 31, 109), Authorization/Precert (CARC 197, 198), Coding/Bundling (CARC 4, 11, 97, B15), Medical Necessity/Non-Covered (CARC 50, 96, 167), Additional Documentation (CARC 252), and Timely Filing (CARC 29).

In Epic, athenaCollector, NextGen, and eClinicalWorks, denial workqueues must be routed by skill set—sending coding/modifier denials to certified coders, medical-necessity denials to clinical appeal specialists, and eligibility denials to registration specialists.

  • Forensic CARC/RARC denial matrix isolating top denial drivers by payer, location, specialty, rendering provider, and CPT code
  • Skill-based denial routing separating administrative corrections from clinical medical-necessity appeals and coding/NCCI disputes
  • Standardized Level I and Level II appeal templates incorporating peer-reviewed clinical guidelines, LCD citations, and ERISA/state prompt-pay rules
  • Closed-loop root-cause governance translating weekly denial trends into front-end registration retraining and clearinghouse edit updates

Free RCM Assessment

Where Is Revenue Being Lost?

Get an independent assessment of your revenue cycle performance, operational gaps and opportunities for improvement.

Please do not submit patient names, medical records, Protected Health Information (PHI), Social Security numbers, or other sensitive patient information through this form. By submitting this form, you acknowledge our Privacy Policy and agree to our Terms of Use.

Why Denial Management Matters to Healthcare Operators ($5M–$100M+ NPR)

Combining rapid, clinical-grade appeal execution with closed-loop upstream root-cause prevention recovers trapped revenue immediately while driving down future denial volume.

For CFOs, VPs of Revenue Cycle, Practice Administrators, MSOs, and PE-backed healthcare platforms operating between $5M and $100M+ in net patient service revenue, even a 150-to-300 basis point slippage in denial management translates into hundreds of thousands—or millions—of dollars in uncollected cash and compressed EBITDA margins.

  • Direct compression of Net Collection Rate (NCR) when preventable denials or contractual variances are written off into bad debt or generic adjustment codes
  • Working-capital drag from elevated Days in A/R and aging receivables past the 90-day and 120-day commercial timely filing and appeal windows
  • Escalating Cost to Collect driven by manual claim touches, clearinghouse rework queues, and administrative staff burnout (estimated at $25–$118 per reworked claim across specialty and acute settings)
  • Distorted executive financial reporting when unbilled holds, unapplied cash, or misclassified contractual adjustments mask true operational run-rate
Denial Management — HFMA MAP Keys & MGMA Executive Performance Benchmarks
KPI / Operational MetricTarget Benchmark RangeWarning / Escalation SignalPrimary Operational Root Cause
Initial Denial Rate (% of Claims / Charges)< 4.0% – 5.0%> 8.0% – 10.0%Broken front-end eligibility/auth handoffs and uncalibrated pre-bill scrubber edits
Denial Overturn / Appeal Recovery Rate60.0% – 80.0%< 40.0%Resubmitting identical claims without clinical rationale, operative notes, or LCD citations
Denied Claims Worked Within 7 Business Days> 90.0%< 60.0%Unprioritized denial queues and commingling denials with routine A/R follow-up
Final Net Denial Write-Off Rate< 1.0% of Net Patient Revenue> 2.5% – 4.0% of NPRSilent administrative write-offs and missed payer appeal deadlines

What to Evaluate First: Independent Denial Management Diagnostic Checklist

An effective evaluation of denial management begins with forensic transaction sampling rather than high-level summary dashboards. Summary reports inside Epic Resolute, athenaCollector, NextGen, or eClinicalWorks frequently blend contractual fee-schedule adjustments with preventable administrative write-offs, hiding the true financial opportunity.

Our diagnostic isolates performance by payer plan, rendering location, specialty, CPT/HCPCS code family, and adjustment reason code so leadership can rank interventions by net cash recovery and implementation effort.

  • True initial denial rate and final net denial write-off rate across all payers
  • CARC/RARC categorization into front-end, mid-cycle coding, and payer policy buckets
  • Denial workqueue prioritization by dollar value and payer-specific appeal deadline
  • Quality and overturn rate of clinical appeals vs. simple claim resubmissions
  • Upstream feedback loops to patient access, prior authorization, and coding leads

Common Mistakes When Switching RCM Vendors or Buying Point Solutions

When denial management metrics deteriorate, healthcare organizations are frequently pitched two polarizing remedies: replace the outsourced billing company entirely, or license an AI/automation bolt-on tool. Both approaches fail when leadership has not diagnosed whether the breakdown sits in clinical documentation, front-desk intake, EHR dictionary mapping, or vendor workqueue execution.

RCM Advisory Partners protects healthcare operators from costly, disruptive missteps by separating internal workflow defects from true vendor or technology limitations before any contract is signed.

  • Simply hitting "resubmit claim" without correcting the underlying coding, modifier, or documentation defect—triggering CARC 18 duplicate denials
  • Allowing high-volume, lower-dollar denials ($75–$300) to age out unworked even when they represent a systemic payer edit defect
  • Measuring denial teams on number of claims touched rather than actual cash recovered and root causes eliminated
  • Failing to escalate systemic commercial payer down-coding or improper bundling patterns to payer relations and contracting leads

How RCM Advisory Partners Structures a 30/60/90-Day Execution Roadmap

Whether the evidence points toward internal workflow optimization, holding an incumbent billing partner accountable to stricter SLAs, or executing a competitive vendor/technology transition, we structure execution around measurable 30/60/90-day milestones.

  1. 01
    Days 1–30: Forensic Baseline, Claim Sampling & Root-Cause Attribution

    Forensic audit of denial management across 837 claims, 835 remittances, EHR workqueues, and payer contracts to quantify exact dollar leakage and root causes.

  2. 02
    Days 31–60: Workflow Re-Engineering, Dictionary Remediation & Vendor SLA Alignment

    Deploy corrected workflow rules, clearinghouse scrubber edits, workqueue routing, and staff or vendor SLA accountability protocols for denial management.

  3. 03
    Days 61–90: Workqueue Stabilization, Prevention Controls & Cash Velocity Tracking

    Validate net cash recovery, first-pass resolution lift, and aging reduction against the Day 1 baseline and transition into monthly KPI governance.

  4. 04
    Ongoing Governance: Executive KPI Scorecards & Managed RCM Advisory

    Monthly executive scorecard tracking HFMA MAP Keys, payer variance alerts, and vendor SLA compliance for denial management.

Frequently Asked Questions

What does an independent denial management assessment examine first?

An independent assessment begins by pulling 6 to 12 months of raw 837 claim files, 277CA clearinghouse acknowledgments, and 835 Electronic Remittance Advice (ERA) data alongside EHR/PM adjustment ledgers. We segment performance by payer, CPT/HCPCS code family, rendering location, and CARC/RARC reason code to determine exactly where earned revenue is being delayed, denied, or written off.

How do we know if our denial management problems are caused by our internal team or our RCM vendor?

We separate front-end and clinical inputs (registration accuracy, eligibility verification, prior authorization intake, provider documentation, and charge lag) from back-office execution (claim scrubbing, coding precision, timely follow-up, appeal quality, and payment posting). By auditing workqueue touch histories and denial root causes, leadership gets an objective attribution model showing which breakdowns belong to internal clinic workflows and which belong to the billing vendor.

Which benchmarks matter most when evaluating denial management?

Using HFMA MAP Keys and MGMA DataDive standards contextualized for your specialty and payer mix, we track First-Pass Resolution Rate (target >=90%–93%), Clean Claim Rate (target >=95%–98%), Initial Denial Rate (target <5%), Days in A/R (target 30–40 days), Aged A/R over 90 days (target <12%–15%), and Net Collection Rate (target 96%–99%).

Should we replace our RCM vendor or EHR system to fix denial management?

Not before diagnosing the root cause. Replacing an RCM vendor or migrating EHR platforms without fixing broken dictionary mappings, front-end registration errors, or missing clinical documentation simply migrates the same defects into a new system while creating 90 to 180 days of transition cash-flow disruption. Often, targeted workflow remediation and enforceable vendor SLAs capture the majority of the financial upside at a fraction of the risk.

How does RCM Advisory Partners support implementation after the assessment?

Depending on the findings, our team can oversee internal workflow re-engineering, lead provider-agnostic RFP and vendor selection processes, manage transition and legacy A/R wind-down, or provide ongoing Managed RCM Advisory oversight with monthly executive scorecards.

Sources & References

  1. CMS Medicare Claims Processing Manual (Pub. 100-04) — Billing, Coding & Timely Filing Rules
  2. HFMA MAP Keys — Healthcare Financial Management Association Revenue Cycle KPI Standards
  3. MGMA DataDive — Medical Group Practice Operations, Cost-to-Collect & A/R Benchmarks
  4. CAQH Index — Annual Report on Healthcare Administrative Transactions, Prior Auth & Claim Cost
  5. X12 / Washington Publishing Company — Claim Adjustment Reason Codes (CARC) & RARC Directory

Next step

Start With the Numbers

Understand where performance is breaking down, what it may be costing your organization, and what should happen next.

Get Your Free RCM Assessment
Call UsGet an Assessment